incidence of gastroparesis with glp 1 GLP-1 receptor agonists and delayed gastric emptying: implications for invasive cardiac interventions and surgery New data links GLP-1 agonists

Heart failure (HF) remains one of the cardiovascular diseases (CVDs) associated with a high unmet medical need due to high morbidity and mortality rates and ...

sin pasos complicados

Berberine Supports insulin sensitivity and weight regulation

The findings highlight an important message: obesity is a chronic condition that often requires personalized, long-term management

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

Protein is key to weight loss, especially on GLP-1 meds like semaglutide and tirzepatide